INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER (EIN 200499338) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

KAREN L KELLY MD

Phone

8554642752

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER, founded in 2003, is a mid-sized nonprofit in the Community Improvement sector that reported $28.6M in total revenue in fiscal year 2024. Revenue grew 16% year-over-year, indicating healthy expansion. Expenses of $26.0M left a modest 9% surplus.

Mission

BE THE MULTIDISCIPLINARY WORLD AUTHORITY ON LUNG AND OTHER THORACIC CANCERS THROUGH COLLLABORATIVE SCIENCE, EDUCATION, AND ADVOCACY IN ORDER TO ENSURE OPTIMAL PREVENTION AND PATIENT CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,373,441

Program Service Revenue $25,769,980

Investment Income $1,142,790

Other Revenue $341,784

TOTAL REVENUE $28,627,995

Expense Breakdown

Grants Paid $1,321,050

Salaries & Benefits $5,392,108

Fundraising Expenses $337,778

Program Expenses $22,056,498

Other Expenses $19,308,321

TOTAL EXPENSES $26,021,479

Year-over-Year Comparison

	2024	2023	Change
Revenue	$28,627,995	$24,616,047	+0.2%
Expenses	$26,021,479	$20,136,070	+0.3%
Net Income	$2,606,516	$4,479,977	-0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$777,102

Total Directors

Key Employees

$713,667

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KAREN L KELLY MD	CEO	40.00	Officer	$465,025	$47,084	$512,109
JOHN SKADOW	CFO	40.00	Officer	$206,433	$47,773	$254,206
MATTHEW YEINGST	VP	40.00	Key Emp	$212,670	$41,536	$254,206
MICHAEL HOEHN	VP	40.00	Key Emp	$229,101	$23,451	$252,552
MURRY WYNES	SENIOR ADVIS	40.00	Highest	$191,362	$21,172	$212,534
JENNIFER KING	VP	32.00	Key Emp	$191,976	$14,933	$206,909
BECKY BUNN	DIRECTOR	40.00	Highest	$147,378	$35,333	$182,711
KATHLEEN DOHERTY	DIRECTOR	40.00	Highest	$135,620	$26,578	$162,198
SUNHEE MALINOWSKI	CONTROLLER	40.00	Highest	$131,820	$15,224	$147,044
KELSEY WOOD	DIRECTOR	40.00	Highest	$131,136	$14,499	$145,635
ELIZABETH DONAHUE	CFO	40.00	Officer	$9,745	$1,042	$10,787
HEATHER WAKELEE MD FASCO	PAST PRESIDE	3.00	Director	$0	$0	$0
JOE CHANG MD PHD FASTRO	DIRECTOR	3.00	Director	$0	$0	$0
MING-SOUND TSAO MD FRCPC	SECRETARY	3.00	Director	$0	$0	$0
NATASHA LEIGHL MD MMSC FRCPC	DIRECTOR	3.00	Director	$0	$0	$0
IGNACIO WISTUBA MD	DIRECTOR	3.00	Director	$0	$0	$0
JHANELLE GRAY MD	DIRECTOR	3.00	Director	$0	$0	$0
PAULA UGALDE MD	DIRECTOR	3.00	Director	$0	$0	$0
LECIA VANDAM SEQUIST MD MPH	DIRECTOR	3.00	Director	$0	$0	$0
ANTONI ROSELL MD PHD	DIRECTOR	3.00	Director	$0	$0	$0
BENJAMIN SOLOMON MBBS PHD	DIRECTOR	3.00	Director	$0	$0	$0
CAICUN ZHOU MD PHD	PRESIDENT EL	3.00	Director	$0	$0	$0
CARLOS GIL FERREIRA MD PHD	DIRECTOR	3.00	Director	$0	$0	$0
JOACHIM AERTS MD PHD	TREASURER	3.00	Director	$0	$0	$0
MORTEN QUIST PHD	DIRECTOR	3.00	Director	$0	$0	$0
PAUL VAN SCHIL MD PHD	PRESIDENT	3.00	Director	$0	$0	$0
WEN-ZHAO ZHONG MD PHD	DIRECTOR	3.00	Director	$0	$0	$0
YOUNG TAE KIM MD PHD	DIRECTOR	3.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$28,627,995	$26,021,479	$35,555,926	$2,606,516
2023	$24,616,047	$20,136,070	$31,025,690	$4,479,977
2022	$11,551,380	$14,627,829	$25,381,895	$-3,076,449
2021	$13,685,313	$11,754,042	$23,299,078	$1,931,271
2020	$6,883,020	$10,088,011	$21,887,506	$-3,204,991
2019	$18,805,451	$17,830,693	$21,412,257	$974,758
2018	$14,022,444	$14,492,345	$18,593,846	$-469,901

INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER